Built for speed, scale, and insights, Illumina Connected Analytics meets the biggest challenges in data engineering. This versatile bioinformatics platform is fully integrated with Illumina sequencing platforms and harnesses the power of DRAGEN. Ready to transform your data bottleneck into a catalyst for scientific discovery?Learn More Request Info
Attain high-quality, reproducible insights using DRAGEN, most comprehensive and leading accuracy for germline and somatic variant calling as measured by PrecisionFDA1.
Minimize hands-on time and seamlessly connect data from across your entire workflow. Illumina software is built for deep sequencer integration and efficient scaling in order to meet your data needs.
Reduce bioinformatics bottlenecks and streamline your entire workflow. Illumina is committed to relentless innovation, creating new bioinformatics technologies that expand access to genomics for all.
The most accurate and comprehensive secondary analysis for next-generation sequencing optimized for efficiency1.
Operationalize bioinformatics workflows with sequencer integration, automatic analysis of customizable workflows, or out-of-the-box DRAGEN pipelines.
Push-button analysis with direct sequencer integration.
Enable high efficiency tertiary analysis workflows for germline research WGS, WES, and panels, with the support of explainable AI (XAI) and user-configured automation to maximize scale potential.
For investigating a sample for a known genotype-phenotype association
Discover new genotype-phenotype associations with software customizable to accelerate new insights
Highly accurate and efficient analysis completely customizable for large scale genomics analysis and discovery at scale
Basepaws is leveraging the Illumina DRAGEN platform and NGS to develop pioneering feline genetic tests that provide pet owners with powerful health insights.
Learn how immunodiagnostics company Verici Dx is utilizing artifical intelligence to support more accurate and tailored care plans for transplant recipients.
Cardiovascular disease (CVD) is the world's leading cause of death. To tackle the issue, Prof. Dr. Andreas Ziegler, scientific director and CEO of Cardio-CARE, is using genomics to study population health data with a clinical focus.
Identify relevant DNA and RNA variants in tumor types and conduct in-house comprehensive genomic profiling of tumor samples.
Visit the Software Resources Portal to access documentation, developer resources, and software news and updatesVisit Portal
Enter your email address.
llumina software solutions are built with the same exceptional level of accuracy, accessibility, and security standards as our sequencing solutions. Our comprehensive bioinformatics suite maximizes efficiency and empowers you to transform your data into insights with powerful tools
for configuration, seamless instrument integration, and approachable user experiences. To help you get up to speed faster, we offer best-in-class implementation support accelerating your utilization of genomics data.
To meet the most stringent security requirements, our software products are built with security and compliance at their core. Data sharing security and governance, audit trails with encryption, and controlled sharing ensure your data is kept safe and secure.
DRAGEN platform on Microsoft Azure provides ultra-rapid secondary analysis capabilities in the cloud, enabling adoption of high-throughput whole-genome sequencing.
Developing and automating best-practice workflows that make analyzing, processing, and disseminating genomic data more accessible.
Phosphorus uses the DRAGEN Bio-IT Platform to perform genomics data analysis onsite and at an accessible price point.